🔎 Trials Near Me

Nyumbani › Colitis ya Ulcerative

Majaribio ya kliniki ya Colitis ya Ulcerative yanayovutia washiriki nchini Marekani

Masomo 79 ya Colitis ya Ulcerative yanavutia washiriki katika vituo vya Marekani nzima.

Miji yenye masomo mengi

Kwa jimbo

Masomo yaliyosasishwa hivi karibuni

Maandishi rasmi ya utafiti (Kiingereza)

Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease

InaajiriUtafiti wa uchunguzi
Umri 18 hadi 85 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT07619547

Aquamin® for Prevention of Ulcerative Colitis J-Pouch-associate Intestinal Inflammation

InaajiriHatua 2
Umri 18 hadi 80 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT07501078

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

InaajiriHatua 4
Umri 18 hadi 80 · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT06581328

A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis

InaajiriHatua 3
Umri 2 hadi 17 · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT07071519

Confirmatory Clinical Study in Active Ulcerative Colitis

InaajiriHatua 2
Umri 16 na zaidi · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT07296315

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

InaajiriHatua 2
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT06598943

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

InaajiriHatua 1/2Wajitolea wenye afya wanakaribishwa
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 29 Sep 2026 · NCT06619990

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

InaajiriHatua 2
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 29 Sep 2026 · NCT07012395

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

InaajiriHatua 2
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 29 Sep 2026 · NCT07845487

Immune Regulation in Ulcerative Colitis or Crohn s Disease

InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
1 Day – 75 Years · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT00001184

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

InaajiriHatua 3
Umri 12 na zaidi · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT07196748

A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

InaajiriHatua 3
Umri 3 na zaidi · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT06663332

A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

InaajiriHatua 2/3
Umri 2 hadi 17 · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT05076175

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 23 Sep 2026 · NCT03816345

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

InaajiriHatua 2
Umri 18 hadi 80 · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07186101

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

InaajiriHatua 2
Umri 18 hadi 80 · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07483073

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

InaajiriHatua 2
Umri 18 hadi 80 · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07415044

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

InaajiriHatua 4
Umri 18 hadi 65 · Jinsia zote · Imesasishwa 21 Sep 2026 · NCT06095128

Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.